T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lymphoma drug safety trial ends early
Disease control TerminatedThis early-stage study tested the safety of the oral drug tazemetostat in 6 adults with peripheral T-cell lymphoma that had returned or stopped responding to prior treatments. The goal was to find a safe dose by watching for side effects in the first month. The study was terminat…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 17, 2026 06:45 UTC
-
Lymphoma study halted early: drug after transplant shows limited promise
Disease control TerminatedThis study looked at whether a drug called duvelisib could help keep T-cell lymphoma from returning after a stem cell transplant. The trial was stopped early and included 17 adults with certain types of T-cell lymphoma. The goal was to see if the drug was safe and could improve h…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 11, 2026 20:46 UTC